サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424051

抗寄生虫薬市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
抗寄生虫薬市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の抗寄生虫薬市場規模は2032年までに382億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

発展途上地域の新興国市場は、抗寄生虫薬市場に絶好の機会を提供します。ヘルスケアのインフラ整備と意識の高まりが、寄生虫感染に対する効果的な治療薬への需要を後押ししています。これらの地域では感染率が高いため、製薬企業はアクセスしやすく手頃な価格のソリューションを導入し、市場参入と拡大のための戦略的提携を確立しています。

標的療法は抗寄生虫薬市場において極めて重要な機会であり、有効性を高め副作用を最小限に抑えるための正確で個別化された治療を提供します。分子理解の進歩を活用したこれらの治療法は、特定の寄生虫に焦点を当て、患者の転帰を改善する革新的な解決策を提供します。このような標的アプローチの研究開発に投資する製薬企業は、市場をリードする立場にあります。この戦略的な動きは、治療法の選択肢を広げると同時に薬剤耐性の課題に対処するものであり、抗寄生虫薬開発における個別化医療の進化に沿ったものです。

臨床試験は、抗寄生虫薬市場の形成において極めて重要な役割を果たしています。安全性と有効性を検証するだけでなく、厳格な臨床試験に参加することで、製薬会社はイノベーターとしての地位を確立します。臨床試験の成功は、規制当局の承認を確保するだけでなく、信頼性を確立し、競争力を獲得します。このような参加はヘルスケア専門家の信頼を醸成し、市場の成長に貢献します。さらに、このような臨床試験により、利用可能な治療選択肢の幅が広がり、寄生虫感染症との闘いにおける進化するニーズに応え、市場の持続的拡大が保証されます。

合理化された規制経路、迅速な承認、支援的な枠組みは、医薬品イノベーションを助長する環境を作り出しています。このような背景により、企業は新規の抗寄生虫薬を迅速に市場に投入し、重要なヘルスケアのニーズに対応することができます。規制当局と業界関係者の協力により、効率的なプロセスが可能となり、タイムリーな市場参入が促進されます。革新的なソリューションの奨励と迅速な規制の枠組みが相まって、抗寄生虫薬市場は持続的な成長を遂げています。

抗寄生虫薬市場レポートハイライト

2023年、蠕虫感染症の流行、世界の保健活動、意識の高まりにより、駆虫薬部門が大きな市場シェアを占めました。

2023年には、迅速かつ直接的な対応と病院での幅広い使用により、注射剤セグメントが大きな市場シェアを占めました。

2023年、病院薬局セグメントは、ヘルスケア機関内で患者が容易にアクセスできることから、大きな収益シェアを占めました。

2023年には、寄生虫感染の流行、規制環境、研究開発により北米地域が世界市場を独占しました。

同市場は、Bayer AG、Cipla Limited、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline、Ipca Laboratories Ltd.、Merck &Co.、Viatris、Novartisなど、世界的に存在感を示す市場企業の存在により、競争が激しいです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の抗寄生虫薬市場に関する洞察

  • 抗寄生虫薬市場 - 流通チャネルのスナップショット
  • 抗寄生虫薬市場力学
    • 促進要因と機会
      • 世界の健康への取り組みが製品需要を刺激すると予測されている
      • 寄生虫感染症の蔓延が抗寄生虫薬市場の成長を促進すると予想される
    • 抑制要因と課題
      • 規制上の課題が市場の成長を妨げる可能性が高い
  • PESTEL分析
  • 抗寄生虫薬市場流通チャネルの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の抗寄生虫薬市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 抗原虫薬
  • 駆虫薬
  • その他

第6章 世界の抗寄生虫薬市場、投与経路別

  • 主な調査結果
  • イントロダクション
  • 局所
  • 経口
  • 注射

第7章 世界の抗寄生虫薬市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 小売薬局
  • 病院薬局
  • その他

第8章 世界の抗寄生虫薬市場、地域別

  • 主な調査結果
  • イントロダクション
    • 抗寄生虫薬市場評価、地域、2019年～2032年
  • 抗寄生虫薬市場 - 北米
    • 北米：抗寄生虫薬市場、タイプ別、2019年～2032年
    • 北米：抗寄生虫薬市場、流通チャネル別、2019年～2032年
    • 北米：抗寄生虫薬市場、投与経路別、2019年～2032年
    • 抗寄生虫薬市場 - 米国
    • 抗寄生虫薬市場 - カナダ
  • 抗寄生虫薬市場 - 欧州
    • 欧州：抗寄生虫薬市場、タイプ別、2019年～2032年
    • 欧州：抗寄生虫薬市場、流通チャネル別、2019年～2032年
    • 欧州：抗寄生虫薬市場、投与経路別、2019年～2032年
    • 抗寄生虫薬市場 - 英国
    • 抗寄生虫薬市場 - フランス
    • 抗寄生虫薬市場 - ドイツ
    • 抗寄生虫薬市場 - イタリア
    • 抗寄生虫薬市場 - スペイン
    • 抗寄生虫薬市場 - オランダ
    • 抗寄生虫薬市場 - ロシア
  • 抗寄生虫薬市場 - アジア太平洋
    • アジア太平洋：抗寄生虫薬市場、タイプ別、2019年～2032年
    • アジア太平洋：抗寄生虫薬市場、流通チャネル別、2019年～2032年
    • アジア太平洋：抗寄生虫薬市場、投与経路別、2019年～2032年
    • 抗寄生虫薬市場 - 中国
    • 抗寄生虫薬市場 - インド
    • 抗寄生虫薬市場 - マレーシア
    • 抗寄生虫薬市場 - 日本
    • 抗寄生虫薬市場 - インドネシア
    • 抗寄生虫薬市場 - 韓国
  • 抗寄生虫薬市場 - 中東・アフリカ
    • 中東・アフリカ：抗寄生虫薬市場、タイプ別、2019年～2032年
    • 中東・アフリカ：抗寄生虫薬市場、流通チャネル別、2019年～2032年
    • 中東・アフリカ：抗寄生虫薬市場、投与経路別、2019年～2032年
    • 抗寄生虫薬市場 - サウジアラビア
    • 抗寄生虫薬市場 - アラブ首長国連邦
    • 抗寄生虫薬市場 - イスラエル
    • 抗寄生虫薬市場 - 南アフリカ
  • 抗寄生虫薬市場 - ラテンアメリカ
    • ラテンアメリカ：抗寄生虫薬市場、タイプ別、2019年～2032年
    • ラテンアメリカ：抗寄生虫薬市場、流通チャネル別、2019年～2032年
    • ラテンアメリカ：抗寄生虫薬市場、投与経路別、2019年～2032年
    • 抗寄生虫薬市場 - メキシコ
    • 抗寄生虫薬市場 - ブラジル
    • 抗寄生虫薬市場 - アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AstraZeneca
  • Bayer AG
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline
  • Ipca Laboratories Ltd
  • Lupin Pharmaceuticals
  • Merck & Co.
  • Novartis
  • Pfizer
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Viatris
  • Zydus Group
図表

List of Tables

  • Table 1 Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 3 Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 7 North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 10 U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 Canada: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Europe: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 UK: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 22 France: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Italy: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 Spain: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Russia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 China: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 46 India: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Japan: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 South Korea: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 67 UAE: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 70 Israel: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 South Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 Latin America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 Mexico: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 82 Brazil: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Argentina: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Antiparasitic Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Antiparasitic Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Antiparasitic Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Antiparasitic Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Antiparasitic Drugs Market
目次
Product Code: PM4409

The global Antiparasitic Drugs market size is expected to reach USD 38.20 billion by 2032, according to a new study by Polaris Market Research. The report "Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Emerging markets in developing regions offer prime opportunities for the Antiparasitic Drugs Market. Improved healthcare infrastructure and heightened awareness drive demand for effective treatments against parasitic infections. With higher infection rates in these regions, pharmaceutical companies introduce accessible and affordable solutions, establishing strategic collaborations for market entry and expansion.

Targeted therapies present a pivotal opportunity in the antiparasitic drugs market, offering precise, personalized treatment for enhanced efficacy and minimized side effects. Leveraging advancements in molecular understanding, these therapies focus on specific parasites, providing innovative solutions with improved patient outcomes. Pharmaceutical companies investing in research and development of such targeted approaches position themselves for market leadership. This strategic move addresses the challenges of drug resistance while expanding treatment options, aligning with the evolving landscape of personalized medicine in antiparasitic drug development.

Clinical trials play a pivotal role in shaping the antiparasitic drugs market. Beyond validating safety and efficacy, participation in rigorous trials positions pharmaceutical companies as innovators. Successful trials not only secure regulatory approvals but also establish credibility, gaining a competitive edge. This engagement fosters confidence among healthcare professionals, contributing to market growth. Furthermore, these trials broaden the spectrum of available treatment options, meeting evolving needs in the fight against parasitic infections and ensuring sustained market expansion.

Streamlined regulatory pathways, expedited approvals, and supportive frameworks create a conducive environment for pharmaceutical innovation. This backing allows companies to swiftly bring novel antiparasitic drugs to market, addressing critical healthcare needs. Collaborative efforts between regulatory bodies and industry players enable efficient processes, fostering timely market entry. The encouragement of innovative solutions, coupled with responsive regulatory frameworks, positions the antiparasitic drugs Market for sustained growth.

Antiparasitic Drugs Market Report Highlights

In 2023, the Anthelmintics segment accounted for significant market share owing to prevalence of helminthic infections, global health initiatives, and increased awareness.

In 2023, the injectable segment accounted for significant market share owing to rapid and direct response, and wide use in hospitals.

In 2023, the hospital pharmacy segment held significant revenue share owing to easy access for patients within healthcare institutions.

In 2023, North America region dominated the global market due to prevalence of parasitic infections, regulatory environment, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including Bayer AG, Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Ipca Laboratories Ltd, Merck & Co., Viatris, and Novartis among others.

Polaris Market Research has segmented the Antiparasitic Drugs market report based on type, route of administration, distribution channel, and region:

Antiparasitic Drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiprotozoals
  • Anthelmintics
  • Others

Antiparasitic Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Topical
  • Oral
  • Injectable

Antiparasitic Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

Antiparasitic Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antiparasitic Drugs Market Insights

  • 4.1. Antiparasitic Drugs Market - Distribution Channel Snapshot
  • 4.2. Antiparasitic Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Global health initiatives are projected to spur the product demand
      • 4.2.1.2. Prevalence of parasitic infections is expected to drive antiparasitic drugs market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antiparasitic Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antiparasitic Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Antiprotozoals
    • 5.3.1. Global Antiparasitic Drugs Market, by Antiprotozoals, by Region, 2019-2032 (USD Billion)
  • 5.4. Anthelmintics
    • 5.4.1. Global Antiparasitic Drugs Market, by Anthelmintics, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Antiparasitic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Antiparasitic Drugs Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Topical
    • 6.3.1. Global Antiparasitic Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 6.4. Oral
    • 6.4.1. Global Antiparasitic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.5. Injectable
    • 6.5.1. Global Antiparasitic Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)

7. Global Antiparasitic Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Retail Pharmacy
    • 7.3.1. Global Antiparasitic Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Hospital Pharmacy
    • 7.4.1. Global Antiparasitic Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Antiparasitic Drugs Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Antiparasitic Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Antiparasitic Drugs Market - North America
    • 8.3.1. North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.4. Antiparasitic Drugs Market - U.S.
      • 8.3.4.1. U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.5. Antiparasitic Drugs Market - Canada
      • 8.3.5.1. Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.4. Antiparasitic Drugs Market - Europe
    • 8.4.1. Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.4. Antiparasitic Drugs Market - UK
      • 8.4.4.1. UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.5. Antiparasitic Drugs Market - France
      • 8.4.5.1. France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.6. Antiparasitic Drugs Market - Germany
      • 8.4.6.1. Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.7. Antiparasitic Drugs Market - Italy
      • 8.4.7.1. Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.8. Antiparasitic Drugs Market - Spain
      • 8.4.8.1. Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.9. Antiparasitic Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.10. Antiparasitic Drugs Market - Russia
      • 8.4.10.1. Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.5. Antiparasitic Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.4. Antiparasitic Drugs Market - China
      • 8.5.4.1. China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.5. Antiparasitic Drugs Market - India
      • 8.5.5.1. India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.6. Antiparasitic Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.7. Antiparasitic Drugs Market - Japan
      • 8.5.7.1. Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.8. Antiparasitic Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.9. Antiparasitic Drugs Market - South Korea
      • 8.5.9.1. South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.6. Antiparasitic Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.4. Antiparasitic Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.5. Antiparasitic Drugs Market - UAE
      • 8.6.5.1. UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.6. Antiparasitic Drugs Market - Israel
      • 8.6.6.1. Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.7. Antiparasitic Drugs Market - South Africa
      • 8.6.7.1. South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.7. Antiparasitic Drugs Market - Latin America
    • 8.7.1. Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.4. Antiparasitic Drugs Market - Mexico
      • 8.7.4.1. Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.5. Antiparasitic Drugs Market - Brazil
      • 8.7.5.1. Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.6. Antiparasitic Drugs Market - Argentina
      • 8.7.6.1. Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AstraZeneca
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr. Reddy's Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Ipca Laboratories Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lupin Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck & Co.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Viatris
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zydus Group
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development